Here is Dirk's tweet from 4 hrs ago:
@RNAiAnalyst: Benitec wants to IPO in US and raise $60-70M, hoping to benefit from interest $BLUE and $QURE: http://t.co/FapRvt3YnT
Poor Dirk may not realize that his post comes from an angle that thinks Benitec is chasing the coattails of other RNAi groups, when in reality we are setting a therapeutic precedent.
